Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 1/20 | 0.32 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.32 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.32 |
| ▸ | PTGIR | P43119 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9546093 | 1.00 | PTGER4 (0.32) | PTGER4PTGER3PTGER2PTGIR | |
| SCHEMBL10619378 | 0.77 | TRPA1 (0.43) | PTGER4PTGER3PTGER2PTGIR | |
| SCHEMBL10619386 | 0.77 | TRPA1 (0.43) | PTGER4PTGER3PTGER2PTGIR | |
| SCHEMBL9546147 | 0.73 | MEN1 (0.31) | — | |
| SCHEMBL9546150 | 0.73 | MEN1 (0.31) | — | |
| SCHEMBL9546036 | 0.73 | PTGER4 (0.30) | PTGER4PTGER3PTGER2 | |
| SCHEMBL10605053 | 0.71 | PTGER4 (0.35) | PTGER4PTGER3PTGER2PTGIR | |
| SCHEMBL10603623 | 0.71 | PTGER4 (0.35) | PTGER4PTGER3PTGER2PTGIR | |
| SCHEMBL10606677 | 0.68 | MAPT (0.37) | PTGER4PTGER3PTGER2PTGIR | |
| SCHEMBL10606689 | 0.68 | MAPT (0.37) | PTGER4PTGER3PTGER2PTGIR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0338796-B1 | 2-SUBSTITUTED-2-CYCLOPENTENONES | TEIJIN LIMITED (JP) | 1993-03-10 | — | — | EP | disclosed |
| US-5116869-A | Antitumor Agents, Bone Formation Accelerator | TEIJIN LIMITED (JP) | 1992-05-26 | — | — | US | disclosed |
| EP-0338796-A2 | 2-Substituted-2-cyclopentenones | TEIJIN LIMITED (JP) | 1989-10-25 | — | — | EP | disclosed |